IP Library Granted Patent US 12,421,540
Granted Patent B2
US 12,421,540 · App. 16/322,462 · Granted Sep 23, 2025

Sequential probing of molecular targets based on pseudo-color barcodes with embedded error correction mechanism

Inventors: Long Cai (Pasadena, CA); Chee Huat Eng (Pasadena, CA); Sheel Shah (Pasadena, CA)
Assignee: CALIFORNIA INSTITUTE OF TECHNOLOGY
C12Q1/6841C12Q2525/161C12Q2537/143C12Q2537/149C12Q2563/107C12Q2563/179C12Q2565/102C12Q2565/514C12Q2565/518
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,421,540
App. No.
16/322,462
Granted
Sep 23, 2025
Kind
B2
Abstract

The present invention, among other things, provides technologies for detecting and/or quantifying nucleic acids in cells, tissues, organs, or organisms. Pre-designed barcodes are associated with specific molecular targets through sequential hybridization experiments. A pseudo-color based barcoding scheme is described that overcomes the limitations in the previous generation of the technology. The current method can be applied to both in vitro and in situ analysis.

Claims (73)

1. A method of barcoding molecular targets in a cell, comprising:

(a) identifying N molecular targets in a cell, wherein N is greater than 500;

(b) performing n sequential barcoding rounds, wherein n≥2, and wherein each barcoding round comprises m serial hybridizations of probes collectively hybridized to the N molecular targets, and wherein m≥2, and wherein m serial hybridizations of probes in each barcoding round are generated by:

(i) contacting one or more groups of probes to a subset of the N molecular targets, the total number of groups of probes corresponding to the number of molecular targets in the subset, wherein probes in each group comprise one or more binding sequences capable of hybridizing to the molecular targets in the subset, wherein each probe is capable of generating at least one detectable signal representing hybridizations of the probes to the molecular targets in the subset, and wherein probes in the one or more groups generate one or more different detectable signals corresponding to the number of molecular targets in the subset;

(ii) detecting detectable visual signals corresponding to the hybridizations between the one or more groups of probes and the subset of the N molecular targets in an image;

(iii) super-localizing the detectable visual signals in the image;

(iv) removing the detectable visual signals, prior to the next serial hybridization;

(v) repeating steps (i)-(iv), each time with a new group of probes capable of hybridizing to a new subset of the N molecular targets;

(c) for each barcoding round in n sequential barcoding rounds, generating a composite image by superimposing m images corresponding to m serial hybridizations, wherein m≥2, and wherein the m images are aligned based on one or more alignment references whose positions remain constant relative to the cell, and wherein the detectable signals in the composite image corresponding to the molecular targets are assigned S pseudo-color symbols;

(d) combining the S pseudo-color symbols from each barcoding round in n sequential barcoding rounds to generate barcodes for the molecular targets, wherein the barcode to each molecular target consists of u unique components, and wherein u≥2, and wherein each unique component in the u unique components is assigned from S unique pseudo-color symbols, and wherein S is an integer that is equal to or greater than

N

n

,

and wherein the molecular targets can be differentiated by one or more differences in their barcodes.

2. The method of claim 1 , wherein the one or more alignment references are selected from the group consisting of an oligonucleotide sequence immobilized on a coverslip and detected by a complementary oligo, a common sequence within all probes, a microscopic object, a metal bead, a gold bead, a polystyrene bead, a PCR handle sequence on a primary binding probe, and combinations thereof.

3. The method of claim 1 , wherein the n sequential barcoding rounds includes x error correction rounds, where x is an integer equal or greater than 1, and wherein assigning barcodes for the N molecular targets requires S unique pseudo-color symbols, wherein S is an integer equal or greater than

N

n

-

x

.

4. The method of claim 1 , wherein the molecular targets comprise nucleic acids, RNA transcripts, proteins, mRNAs, DNA molecules, RNA and DNA isoform molecules, single nucleotide polymorphism molecules, or combinations thereof.

5. The method of claim 4 , wherein the molecular targets comprise RNA transcripts and protein molecules.

6. The method of claim 1 , further comprising:

identifying secondary molecular targets interacting with the N molecular targets by contacting the cell with molecules capable of binding to the secondary molecular targets.

7. The method of claim 6 , wherein the secondary molecular targets comprises RNA binding proteins, ribosomes, DNA binding proteins, transcription factors, chromatin binding proteins, protein binding molecules, scaffold proteins, or combinations thereof.

8. The method of claim 1 , wherein the probes in the one or more groups of probes further comprise:

one or more binding sequences, each binding sequence capable of hybridizing to one or more sites on a molecular target;

one or more readout probe binding sequences, wherein in each barcoding round, only one readout probe binding sequence is associated with a detectable signal for a molecular target, and wherein each readout probe binding sequence is capable of hybridizing a readout probe.

9. The method of claim 8 , wherein each probe comprises one or more readout probe binding sequences.

10. The method of claim 9 , wherein the binding sequence comprises an overhang sequence.

11. The method of claim 10 , wherein the readout probe binding sequences hybridize to readout probes through one or more intermediate molecules.

12. The method of claim 11 , wherein the one or more intermediate molecules are selected from the group consisting of RNA bridge probes, DNA bridge probes, protein bridge probes, hybridization chain reaction (HCR) probes, hairpin nucleic acid probes, HCR initiators, HCR polymers, and combinations thereof.

13. The method of claim 8 , wherein the one or more binding sequences specifically bind to one or more non-nucleic acid sites on the molecular targets.

14. The method of claim 1 , wherein the one or more binding sequences hybridize to different binding sites within the same molecular target.

15. The method of claim 1 , wherein the one or more binding sequences hybridize to different binding sites within different molecular targets.

16. The method of claim 1 , wherein a signal moiety is linked to the binding sequence of a probe or an intermediate molecule via a cleavable linker.

17. The method of claim 1 , wherein the S pseudo-color symbols comprise colors, numbers, letters, shapes, or combinations thereof.

18. The method of claim 1 , wherein, for each serial hybridization, the one or more groups of probes hybridize to non-overlapping subsets of the N molecular targets.

19. The method of claim 1 , wherein one of the S unique pseudo-color symbols is a null signal.

20. The method of claim 1 , wherein N is greater than 720; 1,728; 10,312; 20,736; or 78,125 targets.

21. The method of claim 1 , wherein the probes comprise oligonucleotides and at least one of antibodies or antibody fragments.

22. A method of barcoding molecular targets in a cell, comprising:

(a) identifying N molecular targets in a cell, wherein Nis greater than 500;

(b) performing n sequential barcoding rounds, wherein n≥2, and wherein each barcoding round comprises m serial bindings of probes collectively bound to the N molecular targets, and wherein m≥2, and wherein m serial bindings of probes in each barcoding round are generated by:

i. contacting one or more groups of probes to a subset of the N molecular targets, the total number of groups of probes corresponding to the number of molecular targets in the subset, wherein probes in each group comprise one or more binding sequences capable of binding to the molecular targets in the subset, wherein each probe is capable of generating at least one detectable signal representing bindings of the probes to the molecular targets in the subset, and wherein probes in the one or more groups generate one or more different detectable signals corresponding to the number of molecular targets in the subset;

ii. detecting detectable visual signals corresponding to the bindings between the one or more groups of probes and the subset of the N molecular targets in an image;

iii. super-localizing the detectable visual signals in the image;

iv. removing the detectable visual signals, prior to the next serial bindings;

v. repeating steps (i)-(iv), each time with a new group of probes capable of binding to a new subset of the N molecular targets;

(c) for each barcoding round in n sequential barcoding rounds, generating a composite image by superimposing m images corresponding to m serial bindings, wherein m≥2, and wherein the m images are aligned based on one or more alignment references whose positions remain constant relative to the cell, and wherein the detectable signals in the composite image corresponding to the molecular targets are assigned S pseudo-color symbols;

(e) combining the S pseudo-color symbols from each barcoding round in n sequential barcoding rounds to generate barcodes for the molecular targets, wherein the barcode to each molecular target consists of u unique components, and wherein u≥2, and wherein each unique component in the u unique components is assigned from S unique pseudo-color symbols, and wherein S is an integer that is equal to or greater than

N

n

,

and wherein the molecular targets can be differentiated by one or more differences in their barcodes.

23. The method of claim 22 , wherein the molecular targets comprise nucleic acids, RNA transcripts, proteins, mRNAs, DNA molecules, RNA and DNA isoform molecules, single nucleotide polymorphism molecules, or combinations thereof.

24. The method of claim 23 , wherein the molecular targets comprise RNA transcripts and protein molecules.

25. The method of claim 22 , wherein the probes are selected from proteins, antibodies, antibody fragments, oligonucleotides, and combinations thereof.

26. The method of claim 25 , wherein the probes comprise oligonucleotides and at least one of antibodies or antibody fragments.

27. A method of barcoding molecular targets in a cell, comprising:

(a) identifying N molecular targets in a cell;

(b) performing n sequential barcoding rounds, wherein n≥2, and wherein each barcoding round comprises m serial bindings of probes collectively bound to the N molecular targets, and wherein m≥2, and wherein m serial bindings of probes in each barcoding round are generated by:

i. contacting one or more groups of probes to a subset of the N molecular targets, the total number of groups of probes corresponding to the number of molecular targets in the subset, wherein probes in each group comprise one or more binding sequences capable of binding to the molecular targets in the subset, wherein each probe is capable of generating at least one detectable signal representing bindings of the probes to the molecular targets in the subset, and wherein probes in the one or more groups generate one or more different detectable signals corresponding to the number of molecular targets in the subset;

ii. detecting detectable visual signals corresponding to the bindings between the one or more groups of probes and the subset of the N molecular targets in an image;

iii. removing the detectable visual signals, prior to the next serial bindings;

iv. repeating steps (i)-(iii), each time with a new group of probes capable of binding to a new subset of the N molecular targets;

(c) for each barcoding round in n sequential barcoding rounds, generating a composite image by superimposing m images corresponding to m serial bindings, wherein m≥2, and wherein the m images are aligned based on one or more alignment references whose positions remain constant relative to the cell, and wherein the detectable signals in the composite image corresponding to the molecular targets are assigned S pseudo-color symbols;

(f) combining the S pseudo-color symbols from each barcoding round in n sequential barcoding rounds to generate barcodes for the molecular targets, wherein the barcode to each molecular target consists of u unique components, and wherein u≥2, and wherein each unique component in the u unique components is assigned from S unique pseudo-color symbols, and wherein S is an integer that is equal to or greater than

N

u

,

 and wherein the molecular targets can be differentiated by one or more differences in their barcodes.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 2, 2022
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 060695/0269 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2019
From: CAI, LONG; ENG, CHEE HUAT; SHAH, SHEEL
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 050781/0794 →
Continuity (6)
Continuation In Part 15225820 · Aug 1, 2016
Continuation In Part 15298219 · Oct 19, 2016
Provisional Application 62428910 · Dec 1, 2016
Provisional Application 62456291 · Feb 8, 2017
Provisional Application 62523127 · Jun 21, 2017
Related Publication 20210017587A1 · Jan 21, 2021
References Cited (179)
US 5364763A · Kacian · 1994 [cited by applicant]
US 5367066A · Urdea et al. · 1994 [cited by applicant]
US 5424413A · Hogan et al. · 1995 [cited by applicant]
US 5629147A · Asgari et al. · 1997 [cited by applicant]
US 5866331A · Singer et al. · 1999 [cited by applicant]
US 5955272A · Lawrence et al. · 1999 [cited by applicant]
US 6194146B1 · Utermohlen et al. · 2001 [cited by applicant]
US 6534266B1 · Singer · 2003 [cited by applicant]
US 6537755B1 · Drmanac · 2003 [cited by applicant]
US 7189509B2 · Shao et al. · 2007 [cited by applicant]
US 7727720B2 · Dhallan · 2010 [cited by applicant]
US 8309306B2 · Nolan et al. · 2012 [cited by applicant]
US 10457980B2 · Cai et al. · 2019 [cited by applicant]
US 20010019835A1 · Usui · 2001 [cited by applicant]
US 20010026918A1 · Collins et al. · 2001 [cited by applicant]
US 20020172950A1 · Kenny et al. · 2002 [cited by applicant]
US 20030087279A1 · Shao et al. · 2003 [cited by applicant]
US 20030129611A1 · Bao et al. · 2003 [cited by applicant]
US 20030152490A1 · Trulson et al. · 2003 [cited by applicant]
US 20030170613A1 · Straus · 2003 [cited by applicant]
US 20040171075A1 · Flynn et al. · 2004 [cited by applicant]
US 20040229253A1 · Hyldig-Nielsen et al. · 2004 [cited by applicant]
US 20050069895A1 · Woudenberg et al. · 2005 [cited by applicant]
US 20060275782A1 · Gunderson et al. · 2006 [cited by applicant]
US 20080269068A1 · Church et al. · 2008 [cited by applicant]
US 20090081688A1 · Luo et al. · 2009 [cited by applicant]
US 20100221708A1 · Yamada et al. · 2010 [cited by applicant]
US 20100304994A1 · Wu et al. · 2010 [cited by applicant]
US 20100323348A1 · Hamady et al. · 2010 [cited by applicant]
US 20110104676A1 · Pierce et al. · 2011 [cited by applicant]
US 20120021410A1 · Yin et al. · 2012 [cited by applicant]
US 20120046178A1 · Van Den Boom et al. · 2012 [cited by applicant]
US 20120142014A1 · Cai · 2012 [cited by applicant]
US 20120301886A1 · Farrell et al. · 2012 [cited by applicant]
US 20140031243A1 · Cai et al. · 2014 [cited by applicant]
US 20140073520A1 · Cai et al. · 2014 [cited by applicant]
US 20140099637A1 · Nolan et al. · 2014 [cited by applicant]
US 20140171338A1 · Terbrueggen et al. · 2014 [cited by applicant]
US 20150005188A1 · Levner · 2015 [cited by examiner]
US 20150225801A1 · Cai et al. · 2015 [cited by applicant]
US 20160019334A1 · Cai et al. · 2016 [cited by applicant]
US 20160369329A1 · Cai et al. · 2016 [cited by applicant]
US 20180142307A1 · Cai et al. · 2018 [cited by applicant]
US 20230212658A1 · Cai et al. · 2023 [cited by applicant]
US 20230295697A1 · Cai et al. · 2023 [cited by applicant]
CN 105392898A · 2016 [cited by applicant]
EP 0611828A1 · 1994 [cited by applicant]
EP 2992115B1 · 2020 [cited by applicant]
JP H09168399A · 1997 [cited by applicant]
JP 2002542793A · 2002 [cited by applicant]
JP 2003527075A · 2003 [cited by applicant]
WO WO0065094A · 2000 [cited by applicant]
WO WO03027640A2 · 2003 [cited by applicant]
WO WO2003083440A2 · 2003 [cited by applicant]
WO WO03102239A2 · 2003 [cited by applicant]
WO WO2007001986A2 · 2007 [cited by applicant]
WO WO2010148039A3 · 2010 [cited by applicant]
WO WO2011038403A1 · 2011 [cited by applicant]
WO WO2011048184A1 · 2011 [cited by applicant]
WO WO2011112634A2 · 2011 [cited by applicant]
WO WO20120158967A1 · 2012 [cited by applicant]
WO WO2013096851A1 · 2013 [cited by applicant]
WO WO2014182528A2 · 2014 [cited by applicant]
WO WO2016018960A1 · 2016 [cited by applicant]
Chen et al. Science. 2015. 348(6233): 16 pages and Supplemental Material. (Year: 2015). [cited by examiner]
Eng et al. Nature Methods. 2017. 14(12):1153-115 and Online Methods. (Year: 2017). [cited by examiner]
Examination Report dated Mar. 26, 2021 issued for Canadian Patent Application No. 2,907,493, 5 pages. [cited by applicant]
Final Preliminary Rejection dated Aug. 6, 2021 issued for Korean Patent Application No. 10-2015-7033924, with English translation, 7 pages. [cited by applicant]
Communication Pursuant to 94(3) EPC dated Aug. 2, 2021 issued for European Patent Application No. 19206244.6, 5 pages. [cited by applicant]
Non-Final Office Action mailed Aug. 4, 2021 for U.S. Appl. No. 16/572,511, 18 pages. [cited by applicant]
Ahern, “Biochemical, Reagents KitsOffer Scientists Good Return On Investment”, The Scientist; Jul. 24, 1995; vol. 9(15), pp. 1-7. [cited by applicant]
Giestas, et al: “Multiplexed spectral coding for simultaneous detection of DNA hybridization reactions based on FRET”, Sensors and Actuators B: Chemical; May 2, 2008; vol. 134, pp. 146-157. [cited by applicant]
Lassauniere, et al: “A novel multiplex real-time RT-PCR assay with FRET hybridization probes for the detection and quantitation of 13 respiratory viruses”, Journal of Virological Methods; Feb. 11, 2010; vol. 165, pp. 25… [cited by applicant]
Notice of Reasons for Refusal mailed Dec. 15, 2020 for Japanese Patent Application No. 2019-189650, English translation 10 pages. [cited by applicant]
Communication of a notice of Opposition mailed Dec. 18, 2020 for European Patent No. EP2992115, 148 pages. [cited by applicant]
Communication of notices of Opposition (R.79(1) EPC) mailed Dec. 21, 2020 for European Patent No. EP2992115, 1 page. [cited by applicant]
Consolidated list of references for notice of Opposition mailed Dec. 18, 2020 for European Patent No. EP2992115, 2 pages. [cited by applicant]
Notice of Reasons for Rejection/Notice To File A Response mailed Dec. 29, 2020 for Korean Patent Application No. 10-2015-7033924, with English translation, 9 pages. [cited by applicant]
Almstrand, et al: “New methods for analysis of spatial distribution and coaggregation of microbial populations in complex biofilms”, Applied and Environmental Microbiology; Oct. 2013; vol. 79(19), pp. 5978-5987. [cited by applicant]
Almstrand, et al: D21 Supplement—additional documents (from Consolidated list of references for notice of Opposition mailed Dec. 18, 2020). [cited by applicant]
Choi, et al: “Next Generation in Situ Hybridization Chain Reaction: higher gain, lower cost, greater durability”, ACS Nano; May 27, 2014; vol. 8(5), pp. 4284-4294. [cited by applicant]
Daphnis, et al: “Detailed FISH analysis of day 5 human embryos reveals the mechanisms leading to mosaic aneuploidy”, Human Reproduction 2005; Nov. 26, 2004; vol. 20(1), pp. 129-137. [cited by applicant]
Kris, et al: “High-throughput, high-sensitivity analysis of gene expression in [cited by applicant]
Lubeck, et al: “Single-cell in situ RNA profiling by sequential hybridization”, Nature Methods 2014; Mar. 28, 2014; vol. 11(4), pp. 360-361. (D2 from Consolidated list of references for notice of Opposition mailed Dec. … [cited by applicant]
Lubeck, et al.: D2a Supplementary Information (from Consolidated list of references for notice of Opposition mailed Dec. 18, 2020); FIGURES 1-10 Supplementary Methods and Supplementary Note. [cited by applicant]
Mokros, et al: “Identification of chromosomal fusion sites in [cited by applicant]
Player, et al: “Single-copy gene detection using branched DNA (bDNA) In Situ Hybridization”, Journal of Histochemistry & Cytochemistry 2001; vol. 49(5), pp. 603-611. [cited by applicant]
Uher, et al: “Non-informative results and monosomies in PGD: the importance of a third round of re-hybridization”, Reproductive Bio Medicine Online; Aug. 12, 2009; vol. 19(4), pp. 539-546. [cited by applicant]
VYSIS MultiVysion PGT Multi-color FISH Probe Kit, Abbott Laboratories; Sep. 2014 (D5a from Consolidated list of references for notice of Opposition mailed Dec. 18, 2020). [cited by applicant]
Wang, et al: “A novel in situ RNA analysis platform for Formalin-fixed, Paraffin-embedded tissues”, The Journal of Molecular Diagnostics; Jan. 1, 2012; vol. 14(1); pp. 22-29. [cited by applicant]
First Office Action and Search Report issued Jan. 4, 2022 for Chinese Patent Application No. 201780061639.2, with English translation, 51 pages. [cited by applicant]
Notice of Reasons For Refusal issued Nov. 2, 2021 for Japanese Patent Application No. 2019-189650, with English translation, 5 pages. [cited by applicant]
Communication forwarding the extended European Search Report dated Jun. 26, 2020 issued for European Patent Application No. 17837577.0, 10 pages. [cited by applicant]
Blanco, Ana, et al., “A FRET-based assay for characterization of alternative splicing events using peptide nucleic acid fluorescence in titu hybridization”, Nucleic Acids Research, vol. 37, No. 17, e116 (Jun. 26, 2009). [cited by applicant]
Choi, Harry M.T., et al., “Programmable in situ amplification for multiplexed imaging of mRNA expression”, Nat Biotechnol, vol. 28, No. 11, pp. 1208-1212 (Nov. 2010). [cited by applicant]
Collins, et al., A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml, [cited by applicant]
Eng, et al., Profiling the transcriptome with RNA SPOTs [cited by applicant]
Epstein, Lucy, et al., “Reutilization fo previously hybridized slides for fluorescence in situ hybridization”, Cytometry vol. 21, pp. 378-381 (Year: 1995). [cited by applicant]
Femino, Andrea, et al., “Visualization of signle RNA transcript”, Science 280: 585 (Year: 1998). [cited by applicant]
Fernandez-Suarez, Marta, et al., “Fluorescent probes for super-resolution imaging in living cells”, Molecular Cell Biology, vol. 9, pp. 929-943 (Dec. 2008). [cited by applicant]
Flagella, et al., A multiplex branched DNA assay for parallel quantitative gene expression profiling, Analytical Biochemistry, Mar. 2006, vol. 352, pp. 50-60. [cited by applicant]
Ioannou, D., et al., “Multicolour interphase cytogenetics: 24 chromosome probes, 6 colours, 4 layers”, Molecular and Cellular Probes, vol. 25, pp. 199-205 (Aug. 2011). [cited by applicant]
Kitayama, Yasuhiko, et al., “Repeated fluorescence in situ hybridization by microwave-enhanced protocol”, Pathology International 2006, vol. 56, pp. 490-493. [cited by applicant]
Levesque, Marshall J., et al., “Single-chromosome transcriptional profiling reveals chromosomal gene expression regulation”, Nature Methods, vol. 10, No. 3, pp. 246-248 (Mar. 2013). [cited by applicant]
Levesque, Marshall J., et al., “Visualizing SNVs to quantify allele-specific expression in single cells”, Nature Methods, vol. 10, No. 9, pp. 865-867 (Sep. 2013). [cited by applicant]
Levsky, Jeffrey M., et al., “Single-cell gene expression profiling”, Science 297 : 836 (Year: 2002). [cited by applicant]
Liehr, T., et al., “Multicolor FISH probe sets and their applications”, Histology and Histopathology, vol. 19, pp. 229-237 (Year: 2004). [cited by applicant]
Linton, et al., Microarray Gene Expression Analysis of Fixed Archival Tissue Permits Molecular Classification and Identification of Potential Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Journal Of Molecular Di… [cited by applicant]
Lu, Jing, et al., “Quantification of mIRNA Abundance in single cells using locked nucleic acid-FISH and enzyme-labeled fluorescence”, Methods in Molecular Biology 680:77 (Year: 2011). [cited by applicant]
Lubeck, Eric, et al., “Single-cell in situ RNA profiling by sequential hybridization”, Nature Methods, vol. 1, No. 4, pp. 360-361 (Apr. 2014). [cited by applicant]
Lubeck, Eric, et al., “Single-cell systems biology by super-resolution imaging and combinatorial labeling”, Nature Methods, vol. 9, No. 7, pp. 743-748 (Jul. 2012). [cited by applicant]
Mali, Prashant, et al., “Barcoding cells using cell-surface programmable DNA-binding domains”, Nature Methods vol. 10, No. 5, pp. 403-406 (May 2013). [cited by applicant]
Moffitt, Jeffrey R., et al., “High-throughput single-cell gene-expression profiling with multiplexed error-robust fluorescence in situ hybridization”, PNAS Sep. 27, 2016, vol. 113, No. 39, pp. 11046-11051. [cited by applicant]
Muller, Stefan, et al., “Towards unlimited colors for fluorescence in situ hybridization (FISH)”, Chromosome Research, vol. 10, pp. 223-232 (Year: 2002). [cited by applicant]
Muller, Stefan, et al., “A nonredundant multicolor bar code as a screening tool for rearrangements in neoplasia”, Genes Chromosomes & Cancer, vol. 39, No. 1, pp. 59-70 (Jan. 2004). [cited by applicant]
Pon, et al., Tandem oligonucleotide synthesis using linker phosphoramidites, Nucleic Acids Research, Apr. 6, 2005, vol. 33, No. 6, pp. 1940-1948. [cited by applicant]
Shah, et al., Dynamics and Spatial Genomics of the Nascent Transcriptome by Intron seqFISH Cell (2018) doi.org/10.1016/j.cell.2018.05.035, 15 pages. [cited by applicant]
Sinclair, et al., Improved Sensitivity of BCR-A BL Detection: A Triple Probe Three-Color Fluorescence In Situ Hybridization System, [cited by applicant]
Theodosiou, Zenonas, et al., “Automated analysis of FISH and immunohistochemistry images: a review”, Cytometry Part A, vol. 71A, pp. 439-450 (Year: 2007). [cited by applicant]
Urdea, et al., A comparison of non-radioisotopic hybridization assay methods using fluorescent, chemilluminescent and enzyme labeled synthetic oligodeoxyribonucleotide probes, [cited by applicant]
Velculescu, et al., “Analysis of human transcriptomes”, Nature Dec. 1999, vol. 23, pp. 387-388. [cited by applicant]
Zhen, D.K., et al., “Poly-FISH: A technique of repeated hybridizations that improves cytogenetic analysis of fetal cells in maternal blood”, Prenatal Diagnosis, vol. 18, pp. 1181-1185 (Year: 1998). [cited by applicant]
Communication under Rule 164 EPC with supplementary partial European Search Report dated Jan. 29, 2020 issued for European Patent Application No. 17837577.0, 11 pages. [cited by applicant]
Office Action dated Mar. 6, 2020 issued for Canadian Patent Application No. 2,907,493, 7 pages. [cited by applicant]
Communication forwarding the extended European Search Report dated Feb. 7, 2020 issued for European Patent Application No. 19206244.6, 8 pages. [cited by applicant]
Shah, et al., “In Situ Transcription Profiling of Single Cells Reveals Spatial Organization of Cells in the Mouse Hippocampus”, J. Neuron., NeuroResource Oct. 19, 2019, vol. 92, No. 2, pp. 342-357. [cited by applicant]
Summons to Attend Oral Proceedings under Rule 115(1) EPC dated Nov. 17, 2022 for European Patent Application No. 14795452.3, with updated listing of references; 13 pages. [cited by applicant]
Brief Communication dated Dec. 5, 2022 regarding video-conference for Oral Proceedings for European Patent Application No. 14795452.3; 1 page. [cited by applicant]
First Office Action dated Nov. 2, 2022 for Chinese Patent Application No. 201910951092.4; with English translation (Machine Translation); 16 pages. [cited by applicant]
Miner, et al: “Molecular barcodes detect redundancy and contamination in the hairpin-bisulfite PCR”, Nucleic Acids Research; published online Sep. 30, 2004; vol. 32, No. 17; e35. [cited by applicant]
Weremowicz, et al: “Validation of DNA probes for preimplantation genetic diagnosis (PGD) by fluorescence in situ hybridization (FISH)R1”, Prenat Diagn; published online Sep. 4, 2006; vol. 26; pp. 1042-1050. [cited by applicant]
Opponent's Final Submissions for Oral Proceedings for European Patent Application No. 14795452.3 filed Apr. 14, 2023; 39 pages. [cited by applicant]
Nederlof, et al: “Multiple Fluorescence In Situ Hybridization”, Cytometry 1990; vol. 11, pp. 1126-1131. [cited by applicant]
Office Action dated Feb. 24, 2023 for Korean Patent Application No. 10-2022-7005979; with English translation, 15 pages. [cited by applicant]
Communication Pursuant to Article 94(3)EPC dated Mar. 28, 2023 forwarding the Examination Report for European Patent Application No. 17837577.0; 5 pages. [cited by applicant]
Notification of Reasons for Refusal dispatched May 9, 2023 for Japanese Patent Application No. 2022-074240; with English translation, 13 pages. [cited by applicant]
Office Action for Canadian Patent Application No. 2,907,493 dated May 11, 2023; 5 pages. [cited by applicant]
U.S. Appl. No. 61/817,651 application claimed in PCT/2014/036258, Filed Apr. 30, 2013, Cai, et al. [cited by applicant]
U.S. Appl. No. 61/971,974 application claimed in PCT/2014/036258, Filed Mar. 28, 2014, Cai, et al. [cited by applicant]
Examination Report for Canadian Patent Application No. 3,032,649 dated Jul. 21, 2023; 4 pages. [cited by applicant]
Lee, et al., “Highly multiplexed subcellular RNA sequencing in situ”, Science; Mar. 21, 2014; vol. 343(6177); pp. 1360-1363. [cited by applicant]
20230414 Submission in Opposition Proceedings for EP2992115: Submission List, 2 pages. [cited by applicant]
20230414 Submission in Opposition Proceedings for EP2992115: Letter to EPO Summary of Requests; 7 pages. [cited by applicant]
20230414 Submission in Opposition Proceedings for EP2992115: Letter to EPO Attendee List for Oral Proceedings; 2 pages. [cited by applicant]
20230414 Submission in Opposition Proceedings for EP2992115: Published Evidence 1; Takei, et al., Nature 2021; 53 pages. [cited by applicant]
20230414 Submission in Opposition Proceedings for EP2992115: Published Evidence 2; Eng, et al., Nature 2019; 37 pages. [cited by applicant]
20230414 Submission in Opposition Proceedings for EP2992115: Published Evidence 4; Shah, et al., Cell 2018; 35 pages. [cited by applicant]
20230414 Submission in Opposition Proceedings for EP2992115: New First Auxiliary Request 1 through New Twelfth Auxiliary Request (clean and marked); 71 pages. [cited by applicant]
04142023 EPO Acknowledgment of Receipt (Submission No. 11947234) for written submissions filed for EP2992115; 2 pages. [cited by applicant]
20230614 Opponent additional submission in advance of Oral Proceedings; 23 pages. [cited by applicant]
20230614 Opponent additional submission in Opposition Proceedings made following summons to attend Oral Proceedings; 2 pages. [cited by applicant]
20230614 EPO Acknowledgment of Receipt (Submission No. 12129203) for written submissions filed by opponent; 1 pages. [cited by applicant]
20230614 Letter to EPO; Request For Adjournment of Oral Proceedings; 1 page. [cited by applicant]
20230622 Summons to Oral Proceedings canceled (adjournment granted); 1 page. [cited by applicant]
20230626 Postponement; Summons To Attend Oral Proceedings pursuant to Rule 115(1) EPC; 6 pages. [cited by applicant]
20231005 Submission for Oral Proceedings by Opponent; Letter to EPO; EPO Acknowledgment of Receipt (Submission No. 12497872); Opponent's reply to examination report in opposition proceedings for EP2992115; 5 pages. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: Letter to EPO; EPO Form 1038; 1 page. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: Letter to EPO; EPO Form 1038 Description of Documents filed; 2 pages. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: Letter to EPO; Attendee List for Oral Proceedings; 2 pages. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: Letter to EPO; Summary of Requests; 17 pages. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: D31 Declaration by Michael B. Elowitz, 16 pages. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: D32 Declaration by Arjun Raj, 14 pages. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: D33 Precautions for Handling of RNA; Roche Life Science Products Education Center, https://lifescience.roche.com/global/en/article-listing/article/precaustion… [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: Main Request (clean); 3 pages. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: Main Request (marked); 3 pages. [cited by applicant]
20231006 Submission in Opposition Proceedings for EP2992115: New Auxiliary Request 1 through New Auxiliary Request 21 (clean and marked); 136 pages. [cited by applicant]
20231006 EPO Acknowledgment of Receipt (Submission No. 12505217) for written submissions filed for EP2992115; 1 page. [cited by applicant]
20231006 EPO Acknowledgment of Receipt (Submission No. 12505057) for written submissions filed for EP2992115; 3 pages. [cited by applicant]
Decision of Rejection dated Jun. 27, 2024 for Chinese Patent Application No. 201910951092.4; with English translation, six pages. [cited by applicant]
Examination Report for Canadian Patent Application No. 3,032,649 dated Nov. 19, 2024; 4 pages. [cited by applicant]
20240422 Notification of Appeal Number; Commencement of Proceedings before the Board of Appeal for EP2992115; 7 pages. [cited by applicant]
20240610 Internal EPO Communication regarding Withdrawal of Appeal for EP2992115; 4 pages. [cited by applicant]
20240612 Withdrawal of Appeal for EP2992115; 4 pages. [cited by applicant]
20240613 Closure of Appeal Proceedings EP2992115; 1 page. [cited by applicant]
20240614 Communication Pursuant to Rule 82(2) EPC for EP2992115; 4 pages. [cited by applicant]
EPO Communication Pursuant to 94(3) EPC dated Dec. 20, 2023 forwarding the Examination Report for European Patent Application No. 19206244.6; 6 pages. [cited by applicant]
Notice of Final Rejection dated Nov. 27, 2023 for Korean Patent Application No. 10-2022-7005979; with English translation, 7 pages. [cited by applicant]
Decision To Refuse dated Dec. 26, 2023 for Japanese Patent Application No. 2022-074240; with English translation, 13 pages. [cited by applicant]
EPO Communication dated Feb. 13, 2024 forwarding Interlocutory Decision in Opposition Proceedings for EP2992115; 112 pages. [cited by applicant]
Cited By (2)
US 12,601,007 US 12,630,868